Home
About Us
Technology
Products
- Current Products
  - SENTIA
  - Xprecia Stride
- Laboratory Services
Investor Centre
Contact Us
Search

×

OTHER Latest News

UBI's Canadian subsidiary signs deal with Bayer AGJanuary 05, 2021
UBI Signs Global Deal with LifeScanDecember 22, 2020
Australian Distributor Agreement for SentiaDecember 07, 2020
Q3 2020 ResultsOctober 29, 2020
30 September 2020 Quarterly Activity ReportOctober 22, 2020
Update - Coagulation Business UpdateOctober 22, 2020
Appendix 4D and Half Year Results - 30 June 2020July 24, 2020
CEO's AGM Address to ShareholdersJuly 24, 2020
30 June 2020 Quarterly Activity ReportJuly 20, 2020
Notice of Change of Location of AGMJuly 16, 2020

Investor Information

ASX Share Price
ASX Announcements
Download Annual Report
Hemostasis Reference Lab

2019 Annual Report 23 Mb PDF Document

December 07 2020

Australian Distributor Agreement for Sentia

Australian Distributor Agreement for Sentia

Stay informed on new products and news

Thank You for Subscribing with us

About Universal Biosensors

Universal Biosensors (UBI) began its journey focusing on the research, development and manufacture of devices for the diagnostic point of care (POC) market using UBI’s core technology of a disposable, multi-layer test strip, which incorporates a proprietary electrochemical sensing system that rapidly and accurately measures different biomarkers in blood.

Menu

Careers
Technology
Investor Centre

Products & Services

Current Products
Laboratory Services

Contact Us

Address: 1 Corporate Avenue, Rowville, Victoria, Australia 3178

Telephone: + 61 3 9213 9000

Email Address: info@universalbiosensors.com

Copyright 2020 Universal Biosensors | Privacy Policy | Web Terms & Conditions